Skip to main content

FDA lifts clinical hold on Ocugen's Covid-19 vaccine study; stock skyrockets

The FDA in November temporarily put the brakes on Ocugen's plan to test Covaxin in the United States.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.